老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cue Biopharma, Inc.

0.2394
-0.0115-4.58%
盤後：0.2200-0.0194-8.12%18:40 EDT
成交量：114.04萬
成交額：26.26萬
市值：2,338.00萬
市盈率：-0.85
高：0.2417
開：0.2409
低：0.2224
收：0.2509
52周最高：1.05
52周最低：0.2224
股本：9,766.08萬
流通股本：9,097.21萬
量比：1.31
換手率：1.25%
股息：- -
股息率：- -
每股收益(TTM):-0.2808
每股收益(LYR):-0.2808
淨資產收益率：-121.11%
總資產收益率：-44.56%
市淨率：0.88
市盈率(LYR):-0.85

資料載入中...

總覽公司新聞資訊公告
2021/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/09/17

重要事件披露

8-K - Current report
2020/08/24

重要事件披露

8-K - Current report
2020/08/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/07/15

重要事件披露

8-K - Current report
2020/06/26

重要事件披露

8-K - Current report
2020/06/22

重要事件披露

8-K - Current report
2020/06/05

重要事件披露

8-K - Current report
2020/05/19

重要事件披露

8-K - Current report
2020/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2020/04/29

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/04/21

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/03/27

重要事件披露

8-K - Current report
2020/03/17

重要事件披露

Current report, items 2.02 and 9.01
更多